tiprankstipranks
Trending News
More News >
Arvinas Holding Company (ARVN)
:ARVN
US Market
Advertisement

Arvinas Holding Company (ARVN) Drug Pipeline

Compare
1,030 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Arv-806
Advanced Solid Cancer, Kras G12d Mutation
Phase I/II
Recruiting
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Jun 09, 2025
Arv-393
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (Nhl), Relapsed/Refractory (R/R) Angioimmunoblastic T-Cell Lymphoma (Aitl)
Phase I
Recruiting
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Apr 25, 2024
Anastrozole, Arv-471, Surgical Resection Of Breast Tumor
Breast Cancer
Phase II
Completed
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Sep 07, 2022
Arv-110
Prostate Cancer Metastatic
Phase I/II
Completed
Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer
Mar 21, 2019

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Arvinas Holding Company (ARVN) have in its pipeline
      ARVN is currently developing the following drugs: Arv-806, Arv-393, Anastrozole, Arv-471, Surgical Resection Of Breast Tumor. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis